Successful Genetically Modified Pig Kidney Transplant Boosts MGenSolution's Stock by 29.99%
MGenSolution is in the spotlight following the successful transplantation of a genetically modified pig kidney in the United States.
The company has developed various genetically modified pigs using CRISPR gene-editing technology, which allows for the cutting and modifying of specific genes.
The recent transplantation was conducted on a man in his 60s suffering from end-stage renal disease, and the patient has been in good condition since the surgery.
This successful case used a genetically edited pig kidney provided by eGenesis. MGenSolution's stock price has risen 29.99% on this news.
